Aristada ER 882 MG/3.2 ML syrn 3.2ML
Ended Awarded
- Contract number
- SPE2DB26FL6AC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,929
Award facts
- Contract value 100% obligated
- $1,928.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $1,928.54 from the Defense Logistics Agency (DLA) on October 29, 2025, for the supply of Aristada ER 882 mg/3.2 mL syringes. The award utilizes firm fixed pricing with no set-aside designation and is scheduled for completion by October 30, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026, which authorizes the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency and military healthcare systems. The company has demonstrated substantial capability in fulfilling federal medical supply requirements through competitive awards, with a contract portfolio spanning specialty medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for Aristada ER, an antipsychotic medication delivered via injectable formulation, exemplifies the company's role in providing specialized pharmaceutical products to support military medical operations and veteran healthcare needs.
Quick answers
Who was awarded contract SPE2DB26FL6AC?
SPE2DB26FL6AC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DB26FL6AC worth?
The government has obligated $1,929 on SPE2DB26FL6AC.
Is contract SPE2DB26FL6AC an order under another contract?
Yes. SPE2DB26FL6AC is a delivery order under SPE2DB22D2009, an indefinite delivery contract.
Was contract SPE2DB26FL6AC competed?
The extent of competition for SPE2DB26FL6AC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award